A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer.

about

A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer.Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma.

P2860

Q37284056-F22809AA-67FC-403C-90C1-EDF995A57CBE Q54979771-1805D03B-4B4D-4CE6-AD01-2FB2C33966FC

P2860

A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer.

Item

http://www.wikidata.org/entity/Q41239578

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

A phase II study evaluating ax ...... tastatic head and neck cancer.

@en

type

Item

label

A phase II study evaluating ax ...... tastatic head and neck cancer.

@en

prefLabel

A phase II study evaluating ax ...... tastatic head and neck cancer.

@en

P1476

A phase II study evaluating ax ...... tastatic head and neck cancer.

@en

P2093

Andrew Shuman

http://www.w3.org/2001/XMLSchema#string

Assuntina G Sacco

http://www.w3.org/2001/XMLSchema#string

Carol Bradford

http://www.w3.org/2001/XMLSchema#string

Douglas B Chepeha

http://www.w3.org/2001/XMLSchema#string

Emily Belile

http://www.w3.org/2001/XMLSchema#string

Erin McKean

http://www.w3.org/2001/XMLSchema#string

Francis P Worden

http://www.w3.org/2001/XMLSchema#string

Gregory T Wolf

http://www.w3.org/2001/XMLSchema#string

Irina Dobrosotskaya

http://www.w3.org/2001/XMLSchema#string

Jeffrey Moyer

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Human papillomavirus and survival of patients with oropharyngeal cancer.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group

Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420.

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck.

A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses.

Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial.

P2888

s10637-015-0293-8

P304

1248-1256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10637-015-0293-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Avraham Eisbruch

P577

2015-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1016248988

http://www.w3.org/2001/XMLSchema#string

P698

26453566

http://www.w3.org/2001/XMLSchema#string

A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer.

about

P2860

P2860

A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698